Abiopharma

News list

Director Patel Sushil 🔴 sold 39.3K shares of Replimune Group, Inc. (REPL) at $12.97 Transaction Date: Aug 10, 2026 | Filing ID: 095012

Full text

News bot Aug. 12, 2026, 9:08 p.m.
🔍 Patel Sushil (Director)

Company: Replimune Group, Inc. (REPL)

Report Date: 2026-08-10
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 39,341
Detailed Transactions and Holdings:
- Sold 39,341 shares of Common Stock at $12.97 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 708,151.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the vesting of the Reporting Person's performance-based restricted stock units (the "PSUs"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the PSUs were granted and does not represent a discretionary sale by the Reporting Person.